CD8A and neoplasm: For example, in breast cancer, patients who responded better to neoadjuvant chemotherapy had significantly higher levels of HLA-DR expression among CD8+ T cells that had infiltrated the tumour, compared to non-responders (Saraiva et al., 2018).